Login with your work email address to view charts. No credit card required.
| Art Unit: | 1633 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 800 — Multicellular living organisms and unmodified parts thereof and related processes 536 — Organic compounds -- part of the class 532-570 series 506 — Combinatorial chemistry technology: method, library, apparatus |
| Phone: | (571) 272-0337 |
| Email: | alyssa.weston@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr(Biomedical Engrg) |
| Service: | 4 years |
| Grade: | GS-12 |
| 3-Year Grant rate: | 51% over 57 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 79th
|
With Examiner Weston, you have a 51% chance of getting an issued patent by 3 years after the first office action. Examiner Weston is a harder examiner and in the 79th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Weston, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Weston's grant rate is higher than that of Art Unit 1633 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Weston | 2.1 |
| Art Unit 1633 | 2.0 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.